Molekulare Biomarker bei neuroinflammatorischen Erkrankungen
Article Properties
-
LanguageGerman
-
DOI (url)
-
Publication Date2024/03/01
-
Journal
-
Indian UGC (journal)
-
Refrences55
-
Louisa Müller-Miny
-
Jan Lünemann
Cite
Müller-Miny, Louisa, and Jan Lünemann. “Molekulare Biomarker Bei Neuroinflammatorischen Erkrankungen”. Neurologie up2date, vol. 07, no. 01, 2024, pp. 29-44, https://doi.org/10.1055/a-2122-8968.
Müller-Miny, L., & Lünemann, J. (2024). Molekulare Biomarker bei neuroinflammatorischen Erkrankungen. Neurologie up2date, 07(01), 29-44. https://doi.org/10.1055/a-2122-8968
Müller-Miny L, Lünemann J. Molekulare Biomarker bei neuroinflammatorischen Erkrankungen. Neurologie up2date. 2024;07(01):29-44.
Refrences
| Title | Journal | Journal Categories | Citations | Publication Date |
|---|---|---|---|---|
Update on the diagnosis and treatment of neuromyelits optica spectrum disorders (NMOSD) – revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part I: Diagnosis and differential diagnosis | Journal of Neurology |
| 26 | 2023 |
CSF CXCL13 and Chitinase 3-like-1 Levels Predict Disease Course in Relapsing Multiple Sclerosis | Molecular Neurobiology |
| 7 | 2023 |
Emerging imaging and liquid biomarkers in multiple sclerosis | European Journal of Immunology |
| 8 | 2023 |
Role of autoantibody levels as biomarkers in the management of patients with myasthenia gravis: A systematic review and expert appraisal | European Journal of Neurology |
| 8 | 2023 |
MicroRNAs in oligodendrocyte development and remyelination | Journal of Neurochemistry |
| 11 | 2022 |
Refrences Analysis
The category
Medicine: Internal medicine: Neurosciences. Biological psychiatry. Neuropsychiatry 52
is the most frequently represented among the references in this article. It primarily includes studies from Annals of Clinical and Translational Neurology The chart below illustrates the number of referenced publications per year.